Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pfizer's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
43.97 -0.19    -0.43%
01/02 - Closed. Currency in USD ( Disclaimer )
Pre Market
43.85
-0.12
-0.27%
6:10:06 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 24,133,470
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 43.41 - 44.18
Pfizer 43.97 -0.19 -0.43%

Pfizer Inc Company Profile

 
Get an in-depth profile of Pfizer Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

79000

Equity Type

ORD

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.

Contact Information

Top Executives

Name Age Since Title
Susan J. Hockfield 70 2020 Independent Director
Daniel R. Littman 69 2018 Independent Director
Albert Bourla 60 2016 Chairman of the Board & CEO
Suzanne M. Nora Johnson 65 2007 Independent Director
Ronald E. Blaylock 62 2017 Independent Director
James C. Smith 62 2014 Independent Director
Shantanu Narayen 58 2013 Lead Independent Director
Helen H. Hobbs 70 2011 Independent Director
Joseph J. Echevarria 65 2015 Independent Director
James Robert B. Quincey 57 2020 Independent Director
Scott Gottlieb 49 2019 Independent Director
Charles T. Hagel 76 - Member of Emerging Markets Advisory Board
Susan Desmond-Hellmann 65 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
sayed Elsayed
sayed Elsayed 19 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why that share can't get up inspite of good financial feedbacks? I 🙄
Ben Rudin
Ben Rudin 11 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
propaganda
Romulus Son of Mars
Romulus7 Jan 31, 2023 12:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol. all those shots and can't beat revenue? money must have gone somewhere else 🤣
Invest Right
Invest Right Jan 31, 2023 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
clot shot
Ben Rudin
Ben Rudin Jan 31, 2023 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
corrupted company, search project veritage video
Ben Rudin
Ben Rudin Jan 31, 2023 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
veritias*
Jay Clerk
Jay Clerk Jan 31, 2023 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow dump in pre market or get slammed interest rate damage coming tomorrow. Short it get em back
Jay Clerk
Jay Clerk Jan 26, 2023 11:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Project veritage video is going viral ,timber!
Jay Clerk
Jay Clerk Jan 26, 2023 8:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This turdsucker is easy money short short and short again
peter pan
peter pan Jan 25, 2023 5:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer is the best short stock ever. I always like to short this worthless stock.
damian del
mudlog79 Jan 24, 2023 12:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short this trash scam to the ground
Ron Maselko
Ron Maselko Jan 23, 2023 12:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
on the decline due to not telling about all the adverse reactions to shots. just general info
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email